v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Net sales $ 85,426
Cost of goods sold 1,696
Gross profit 83,730
Operating Expenses    
Research and development 402,387 1,353,050
Selling, general and administrative 1,455,636 1,779,619
Total operating expenses 1,858,023 3,132,669
Operating loss (1,774,293) (3,132,669)
Other Income (Expense)    
Change in fair value of derivative liabilities 561,350 12,417,450
Interest income 191 16,271
Interest expense (147,233) (106,422)
Other (expense) (70,683)
Total other income 343,625 12,327,299
Net (loss) income before provision for income taxes (1,430,668) 9,194,630
Provision for income taxes
Net (loss) income $ (1,430,668) $ 9,194,630
Weighted average number of shares of common stock outstanding, basic (in Shares) 7,786,342 3,001,784
Basic net (loss) income per share of common stock (in Dollars per share) $ (0.18) $ 3.06
Weighted average number of shares of common stock outstanding, diluted (in Shares) 7,786,342 3,048,833
Diluted net loss per share of common stock (in Dollars per share) $ (0.18) $ (0.3)